DJ Biogen Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 1.10% to $190.48 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.08% to 6,775.80 and Dow Jones Industrial Average falling 0.61% to 47,417.27.
This was the stock's third consecutive day of gains.
Biogen Inc. closed 5.89% below its 52-week high of $202.41, which the company achieved on February 6th.
The stock outperformed some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 0.30% to $242.99, Pfizer Inc. $(PFE)$ rose 0.52% to $27.30, and AbbVie Inc. $(ABBV)$ rose 0.30% to $227.68.
Trading volume (863,947) remained 489,236 below its 50-day average volume of 1.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 11, 2026 16:59 ET (20:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments